AK-568

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameAK-568
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionCaspase-3 modulatorsEpidermal growth factor receptor erbB1 antagonistsAnticancer protein kinase inhibitors
TargetsEpidermal growth factor receptor erbB1Caspase-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesHuaqiao University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHuaqiao University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A